The World Health Organization has delivered more than a million doses of antibiotics to Madagascar amid a raging epidemic of plague in which at least 33 people have died and 230 others have been infected, the BBC reported.
The first confirmed death from the epidemic began on August 28th in the town of Moramanga,.“Plague is curable if detected in time. Plague first arrived in Madagascar from Indian steamboats in 1898 before spreading through other harbors and then into the mainland along railroad construction lines.
The Association of American Medical Colleges predicted that by 2030, the United States would have a shortage of up to 104,900 physicians. To try to curb this impending crisis, a wave of new medical schools have opened in the last decade. Eleven schools have been accredited by the Liaison Committee on Medical Education in the last five years, and eight more are currently under consideration.
As a condition of accreditation, these new schools must provide access to “well-maintained library resources sufficient in breadth of holdings and technology” to support the school’s educational mission, however, many medical schools are deciding that large print collections are no longer a vital component of those resources.
Charles Stewart, associate dean and chief librarian of City College of New York, of the City University of New York system, said that his institution chose to go a paperless route for the newly opened CUNY School of Medicine on the City College campus for much the same reason — 24-7 access. “Stewart says they chose the all-electronic option since their medical school clearly wanted instant e-access to all their resources.
The Frank H. Netter School of Medicine at Quinnipiac University, which accepted its first students in 2013, is designed as a paperless institution. The school has a library space where students can read and study, but the vast majority of the library’s resources are online. Bruce Koeppen, dean of the school, said that by making most of the library’s holdings electronic, it ensured that students and faculty could access information “anywhere and anytime, even when the library is closed.”
The Virginia Tech Carilion School of Medicine, opened in 2010, with just 50 books on its shelves, however, the students quickly pushed to expand this collection to 4,000 books, saying that they preferred to use physical materials for studying. The school noted, however, that it did not want to increase its print collection beyond the current level.
Fay Towell, director of libraries at the Greenville Hospital System, said that it was interesting that students at the University of South Carolina School of Medicine Greenville, which opened in 2012, frequently requested access to both print and electronic resources. Given the small size of the library, and the prohibitive cost of providing both print and online versions of texts, Towell said the library had to be selective. She noted that often journals might cost more electronically than in print — “if a journal cost is $4,000 electronically and $400 in print, then the library makes space for print,” she said.
Roger Schonfeld, director of the Library and Scholarly Communication Program for Ithaka S+R, pointed out that when medical libraries thin their print collections, it does not necessarily mean that the campus loses access to those physical materials. “Whether the collections are moved to an off-site facility, or the library participates in a shared print program, it is almost always still possible to provide access to a print version on those occasions when it is necessary to do so.” The trend for thinning print collections is not unique to medical libraries, said Schonfeld — many science and engineering libraries have done the same.
New Jersey-based Hackensack Meridian Health has teamed up with the New Jersey Innovation Institute (NJIT) to open a health incubator with a design similar to the reality show ”Shark Tank,” in which companies pitch healthcare innovation ideas to a panel of experts. The incubator, Agile Strategies Lab, is the first of its kind for healthcare advances in New Jersey, according to officials. The lab, located on the New Jersey Institute of Technology (NJIT) campus in Newark, is designed to help create and launch the next wave of problem-solving in healthcare through better devices, improved technology and more efficient services to provide a higher quality of care, lower costs, and an enhanced patient experience, officials said in an announcement.
Hackensack Meridian Health has committed $25 million, a new revenue stream to help companies develop trailblazing products and services. This seed money will help launch ideas to the point where they can become viable and receive financing through venture capitalists. And the organization’s vast network—13 hospitals in seven counties, and more than 100 outpatient centers and 6,000 physicians—will look to serve as a vehicle to test some of the innovations once they are advanced enough as determined by a panel of experts from multiple disciplines.
Penn State professor Ibrahim Ozbolat and his team has engineered a solution to worn out knees. They’re producing cartilage patches to repair defects. Since there are no blood vessels in cartilage tissue, so the researchers said it’s a good type of tissue for bio-printing. In the future, Ozbolat says, stem cells would be removed from a patient and cultured in a lab. The cartilage is printed and then transplanted back into a patient. This will allow scientists to print new and compatible human parts someday.
Dr Jeffrey Lieberman from Columbia University says” the new technologic innovation that is emerging and which does seem likely to impact psychiatry and mental health care in a time that is commensurate with the other specialties of medicine, is the technology that informs how we use Internet-based smartphone mobile app devices. The rudimentary ways in which this has already begun to permeate medicine and mental health care include electronic health records and telemedicine, which is ideally suited to psychiatry in terms of being able to provide consultation at a distance.“The initial idea is to have smartphone-based applications that can perform several functions. One is a monitoring function: having apps that can passively monitor the activities or biologic signals of an individual—whether it is movement, heart rate, respiratory rate, or level of activity—and have an ongoing record that can be catalogued, observed, and interpreted by clinicians. A second function is as a means of communication. Doctors already have begun to employ FaceTime, Skype, and texting to maintain contact with patients remotely in a variety of situations. Another area would be to develop apps that could provide some kind of actual therapeutic assistance, including cognitive-behavioral therapy, motivational interviewing, and supportive types of techniques or protocols when needed. All of these have great potential and can expand the reach of healthcare providers, psychiatrists, and mental health care clinicians, and provide help to a larger proportion of people when they need it.”
23andMe first debuted direct-to-consumer tests meant to predict disease in 2013, but the U.S. Food and Drug Administration quickly clamped down on that and told the company to stop marketing the tests, saying they could be inaccurate and confusing to consumers.
However, the company was vindicated earlier this year when the FDA revised that decision, declaring 23andMe could sell tests that estimate customers’ risk of certain disease, as long as they don’t purport to diagnose any disease.
Early this year, Illumina, the manufacturer of most of the world’s DNA sequencers, unveiled its newest, most efficient machine, NovaSeq, which can sequence as many as 48 entire human genomes in two and a half days, according to the company. Illumina claims the ultra-fast machine will usher in the $100 genome and will open the door for researchers to cheaply sequence DNA in search of rare genetic variants that cause disease.
Sophia Genetics is taking a big-data approach to DNA. The Swiss company is using AI algorithms to continuously learn from thousands of patients’ genomic data. Partnering hospitals take patient samples and run them through a DNA sequencer. The Sophia system sifts through that genetic information to identify mutations in a patient’s genome. The technology is said to quickly and more accurately diagnose conditions like cancer, metabolic disorders, and heart disease.
Sir Venki Ramakrishnan says risks and benefits of germline therapy, which is banned in Britain, should be debated
An international team of scientists, led by researchers at the Oregon Health and Science University, has used genetic engineering on human sperm and a pre-embryo. The group says is doing basic research to figure out if new forms of genetic engineering might be able to prevent or repair terrible hereditary diseases. Congress has banned federal funding for genetic engineering of sperm, eggs, pre-embryos or embryos. That means everything goes on in the private or philanthropic world here or overseas, without much guidance. It should be determined who should own the techniques for genetic engineering. Important patent fights are underway among the technology’s inventors. Which means lots of money. is at stake. And that means it is time to talk about who gets to own what and charge what. Finally, human genetic engineering needs to be monitored closely: all experiments registered, all data reported on a public database and all outcomes — good and bad — made available to all scientists and anyone else tracking this area of research. Secrecy is the worst enemy that human genetic engineering could possibly have. Today we need to focus on who will own genetic engineering technology, how we can oversee what is being done with it and how safe it needs to be before it is used to try to prevent or fix a disease. Plenty to worry about.